| abstract |
IT REFERS TO A TRANSMUCOSAL, SUBLINGUAL OR ORAL PHARMACEUTICAL ADMINISTRATION COMPOSITION THAT INCLUDES: A) DEXMEDETOMIDINE OR A PHARMACEUTICALLY ACCEPTABLE SALT SUCH AS HYDROCHLORIDE IN A DOSAGE BETWEEN 0.05? G / kg; AND 1.50? G / kg; AND B) A PHARMACEUTICALLY ACCEPTABLE LIQUID EXCIPIENT SUCH AS AN AQUEOUS SOLUTION OF DEXMEDETOMIDINE HYDROCHLORIDE. SAID PHARMACEUTICAL COMPOSITION IS AN ANALGESIC BEING USEFUL IN THE TREATMENT OF PAIN SUCH AS NEURALGIA, MIALGIA, HYPERALGIA, NEURITIS, AMONG OTHERS, ASSOCIATED OR CAUSED BY CANCER, VIRAL INFECTION, PHYSICAL TRAUMA, ARTHRITIS |